Latest Breaking News On - Irsevimab san fr0000120578 - Page 1 : comparemela.com

Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreements Modification of existing collaboration agreement with AstraZeneca gives Sanofi full commercial control of nirsevimab and. | April 11, 2023

France generalUnited statesTarik elgoutniEvan berlandSandrine guendoulFelix lauscherCorentine driancourtEva schaefer jansenNathalie phamEuropean unionCollaboration agreementSanofi stock exchangePress releaseIrsevimab san fr0000120578